Devlin J, Wong P, Williams R, Neuhaus P,
McMaster P, Calne R, Pichlmayr R, Otto G, Bismuth H, Groth C. FK
506 primary immunosuppression following emergency liver
transplantation for fulminant hepatic failure. European FK 506
Study Liver Group Transpl Int. 1994;7 Suppl 1:S64-9.
Mondragon RS, Karani JB, Heaton ND, Thomas S, Wong
PY, O'Grady JG, Tan KC
and Williams R. The use of percutaneous transluminal angioplasty in
hepatic artery stenosis after transplantation. Transplantation,
1994; 57 (2): p. 228-31.
Marinos G, Naoumov NV, Rossol S, Torre F, Wong
PY, Gallati H, Portmann B and Williams R. Tumor necrosis
factor receptors in patients with chronic hepatitis B virus
infection. Gastroenterology, 1995; 108 (5): p.
1453-63.
Wong PY, Marinos G, Peakman M, Tredger JM, Lau
JY, Vergani D, Naoumov NV
and Williams R. FK506 in liver transplantation for chronic
hepatitis B: in vitro studies on lymphocyte activation and virus
replication. Liver Transplantation & Surgery, 1995; 1
(6): p. 362-70.
Marinos G, Rossol S, Carucci P, Wong PY,
Donaldson P, Hussain MJ, Vergani D, Portmann BC, Williams R,
Naoumov NV. Immunopathogenesis of hepatitis B virus recurrence
after liver transplantation. Transplantation. 2000,
69(4):559-68.
Dalton HR, Fellows HJ, Gane EJ, Wong P, Gerred
S, Schroeder B, Croxson MC, Garkavenko O. Hepatitis E in New
Zealand. J Gastroenterol Hepatol 2007, 22;8:1236-40.
Book: J Ramage, P Wong, K Hayllar, R Williams.
Overall survival results: quality of life and management. In "The
Practice of Liver Transplantation". Editors Roger Williams, Bernard
Portmann and K-C Tan. Churchill Livingston, London & Edinburgh,
1995. Pages 257-270.